Your account is not claimed yet. You can sign up with ORCID to claim your account.

Benedict-Tilmann Berger (Benedict-Tilman Berger)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 20

Top Venues

Journal of medicinal chemistry

ACS chemical biology

Nature chemical biology

ChemMedChem

Structural Genomics Consortium Frankfurt

Goethe-Universität Frankfurt am Main Fachbereich 14 Biochemie Chemie und Pharmazie (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Structural Genomics Consortium Frankfurt Oct 27o 2016

Germany

PhD Student :: Pharmaceutical Chemistry

Education History

Goethe-Universität Frankfurt am Main Fachbereich 14 Biochemie Chemie und Pharmazie Oct 27o 2016

Germany

PHD :: Structural Genomics Consortium, Pharmaceutical Chemistry

Publications

Jennifer A Amrhein, Guiqun Wang, Benedict-Tilmann Berger, Lena Marie Berger, Amalia D Kalampaliki, Andreas Krämer, Stefan Knapp, Thomas Hanke
Design and Synthesis of Pyrazole-Based Macrocyclic Kinase Inhibitors Targeting BMPR2. ACS medicinal chemistry letters 14 (6) (2023)
Maria Reinecke, Paul D Brear, Larsen Vornholz, Benedict-Tilmann Berger, Florian Seefried, Stephanie Wilhelm, Patroklos Samaras, Laszlo Gyenis, David William Litchfield, Guillaume Médard, Susanne Müller, Jürgen Ruland, Marko Hyvönen, Mathias Wilhelm, Bernhard Kuster
Chemical proteomics reveals the target landscape of 1,000 kinase inhibitors. Nature chemical biology (2023)
Claudia Tredup, Benardina Ndreshkjana, Natalie S Schneider, Amelie Tjaden, Aurino M Kemas, Sonia Youhanna, Volker Martin Lauschke, Benedict-Tilmann Berger, Andreas Krämer, Lena Marie Berger, Sandra Röhm, Stefan Knapp, Henner F Farin, Susanne Müller
Deep Annotation of Donated Chemical Probes (DCP) in Organotypic Human Liver Cultures and Patient-Derived Organoids from Tumor and Normal Colorectum. ACS chemical biology (2023)
Sandrine Baltzer, Timur Bulatov, Christopher Schmied, Andreas Krämer, Benedict-Tilmann Berger, Andreas Oder, Ryan Walker-Gray, Christin Kuschke, Kerstin Zühlke, Jenny Eichhorst, Martin Lehmann, Stefan Knapp, John Weston, Jens Peter von Kries, Roderich D Süssmuth, Enno Klussmann
Aurora Kinase A Is Involved in Controlling the Localization of Aquaporin-2 in Renal Principal Cells. International journal of molecular sciences 23 (2) (2022)
Martin Schröder, Matthias Leiendecker, Ulrich Grädler, Juliane Braun, Andreas Blum, Marek Wanior, Benedict-Tilmann Berger, Andreas Krämer, Susanne Müller, Christina Esdar, Stefan Knapp, Timo Heinrich
MSC-1186, a Highly Selective Pan-SRPK Inhibitor Based on an Exceptionally Decorated Benzimidazole-Pyrimidine Core. Journal of medicinal chemistry 66 (1) (2022)
Christian G Kurz, Franziska Preuss, Amelie Tjaden, Martin Cusack, Jennifer Alisa Amrhein, Deep Chatterjee, Sebastian Mathea, Lena Marie Berger, Benedict-Tilmann Berger, Andreas Krämer, Michael Weller, Tobias Weiss, Susanne Müller, Stefan Knapp, Thomas Hanke
Illuminating the Dark: Highly Selective Inhibition of Serine/Threonine Kinase 17A with Pyrazolo[1,5- a ]pyrimidine-Based Macrocycles. Journal of medicinal chemistry 65 (11) (2022)
Thomas Hanke, Sebastian Mathea, Julia Woortman, Eidarus Salah, Benedict-Tilmann Berger, Anthony Tumber, Risa Kashima, Akiko Hata, Bernhard Kuster, Susanne Müller, Stefan Knapp
Development and Characterization of Type I, Type II, and Type III LIM-Kinase Chemical Probes. Journal of medicinal chemistry 65 (19) (2022)
Aziz M Rangwala, Benedict-Tilmann Berger, Matthew B Robers, Stefan Knapp, Markus A Seeliger
Resistance to kinase inhibition through shortened target engagement. Molecular & cellular oncology 9 (1) (2022)
Martin Schröder, Matthias Leiendecker, Ulrich Grädler, Juliane Braun, Andreas Blum, Marek Wanior, Benedict-Tilmann Berger, Andreas Krämer, Susanne Müller, Christina Esdar, Stefan Knapp, Timo Heinrich
MSC-1186, a Highly Selective Pan-SRPK Inhibitor Based on an Exceptionally Decorated Benzimidazole-Pyrimidine Core. Journal of medicinal chemistry 66 (1) (2022)
Milan Hluchý, Pavla Gajdušková, Ruiz De Los Mozos Igor, Michal Rájecký, Michael Kluge, Benedict-Tilmann Berger, Zuzana Slabá, David Potěšil, Elena Weiβ, Jernej Ule, Zbyněk Zdráhal, Stefan Knapp, Kamil Paruch, Caroline C Friedel, Dalibor Blazek
CDK11 regulates pre-mRNA splicing by phosphorylation of SF3B1. Nature 609 (7928) (2022)
Martin Schröder, Matthias Leiendecker, Ulrich Grädler, Juliane Braun, Andreas Blum, Marek Wanior, Benedict-Tilmann Berger, Andreas Krämer, Susanne Müller, Christina Esdar, Stefan Knapp, Timo Heinrich
MSC-1186, a Highly Selective Pan-SRPK Inhibitor Based on an Exceptionally Decorated Benzimidazole-Pyrimidine Core. Journal of medicinal chemistry 66 (1) (2022)
Martin Schröder, Matthias Leiendecker, Ulrich Grädler, Juliane Braun, Andreas Blum, Marek Wanior, Benedict-Tilmann Berger, Andreas Krämer, Susanne Müller, Christina Esdar, Stefan Knapp, Timo Heinrich
MSC-1186, a Highly Selective Pan-SRPK Inhibitor Based on an Exceptionally Decorated Benzimidazole-Pyrimidine Core. Journal of medicinal chemistry (2022)
Ricardo A M Serafim, Fiona J Sorrell, Benedict-Tilmann Berger, Ross J Collins, Stanley N S Vasconcelos, Katlin B Massirer, Stefan Knapp, James Bennett, Oleg Fedorov, Hitesh Patel, William J Zuercher, Jonathan M Elkins
Discovery of a Potent Dual SLK/STK10 Inhibitor Based on a Maleimide Scaffold. Journal of medicinal chemistry 64 (18) (2021)
Florian Wittlinger, David E Heppner, Ciric To, Marcel Günther, Bo Hee Shin, Jaimin K Rana, Anna M Schmoker, Tyler S Beyett, Lena Marie Berger, Benedict-Tilmann Berger, Nicolas Bauer, James D Vasta, Cesear R Corona, Matthew B Robers, Stefan Knapp, Pasi A Jänne, Michael J Eck, Stefan A Laufer
Design of a "Two-in-One" Mutant-Selective Epidermal Growth Factor Receptor Inhibitor That Spans the Orthosteric and Allosteric Sites. Journal of medicinal chemistry (2021)
Roberta Tesch, Marcel Rak, Monika Raab, Lena Marie Berger, Thales Kronenberger, Andreas C Joerger, Benedict-Tilmann Berger, Ismahan Abdi, Thomas Hanke, Antti Poso, Klaus Strebhardt, Mourad Sanhaji, Stefan Knapp
Structure-Based Design of Selective Salt-Inducible Kinase Inhibitors. Journal of medicinal chemistry 64 (12) (2021)
Martin Reynders, Apirat Chaikuad, Benedict-Tilmann Berger, Katharina Bauer, Pierre Koch, Stefan A Laufer, Stefan Knapp, Dirk H Trauner
Controlling the Covalent Reactivity of a Kinase Inhibitor with Light. Angewandte Chemie (International ed. in English) 60 (37) (2021)
Sandra Röhm, Benedict-Tilmann Berger, Martin Schröder, Deep Chatterjee, Sebastian Mathea, Andreas C Joerger, Daniel M Pinkas, Joshua C Bufton, Amelie Tjaden, Lohitesh Kovooru, Mark Kudolo, Christian Pohl, Alex N Bullock, Susanne Müller, Stefan A Laufer, Stefan Knapp
Development of a Selective Dual Discoidin Domain Receptor (DDR)/p38 Kinase Chemical Probe. Journal of medicinal chemistry 64 (18) (2021)
Thomas Hanke, Jong Fu Wong, Benedict-Tilmann Berger, Ismahan Abdi, Lena Marie Berger, Roberta Tesch, Claudia Tredup, Alex N Bullock, Susanne Müller, Stefan Knapp
A Highly Selective Chemical Probe for Activin Receptor-like Kinases ALK4 and ALK5. ACS chemical biology 15 (4) (2020)
Júlia G B Pedreira, Philipp Nahidino, Mark Kudolo, Tatu Pantsar, Benedict-Tilmann Berger, Michael Forster, Stefan Knapp, Stefan A Laufer, Eliezer Jesus Barreiro
Bioisosteric Replacement of Arylamide-Linked Spine Residues with N-Acylhydrazones and Selenophenes as a Design Strategy to Novel Dibenzosuberone Derivatives as Type I 1/2 p38α MAP Kinase Inhibitors. Journal of medicinal chemistry 63 (13) (2020)
Alix Tröster, Stephanie Heinzlmeir, Benedict-Tilmann Berger, Santosh L Gande, Krishna Saxena, Sridhar Sreeramulu, Verena Linhard, Amir H Nasiri, Michael Bolte, Susanne Müller, Bernhard Kuster, Guillaume Médard, Denis Kudlinzki, Harald Schwalbe
NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. ChemMedChem 13 (16) (2018)

Benedict-Tilmann Berger.css-eqlu8i{font-size:small;padding-left:4px;} (Benedict-Tilman Berger)

Publication Activity (10 Years)

Top Topics

Top Venues

Benedict-Tilmann Berger (Benedict-Tilman Berger)